PITPNM3 and familial pancreatic carcinoma: PITPNM3 has also been found to promote the progression of various tumours, such as breast (Zeng et al., 2023) and pancreatic cancer (Meng et al., 2015), which is an emerging therapeutic target in cancer (Torphy et al., 2022).